Companies

curl "https://conductscience.org/api/companies/v1"

Response

The first 2 of this page's 20 results. GET /api/companies/v1

{
  "data": {
    "total": 18985,
    "results": [
      {
        "id": "glaxosmithkline-b97dbf35",
        "title": "GlaxoSmithKline",
        "summary": "4,951 trials, 3,650 as lead sponsor, 1,301 as collaborator; 155 recruiting; 2,208 with posted results; 830 drugs on its trials.",
        "record": "/library/companies/glaxosmithkline-b97dbf35",
        "names": null,
        "trials": 4951,
        "roles": "3,650 as lead sponsor, 1,301 as collaborator",
        "recruiting": 155,
        "with_results": 2208,
        "drugs": 830,
        "phases": "Phase 1 1,397, Phase 2 1,266, Phase 3 1,099, Phase 4 539"
      },
      {
        "id": "pfizer-69d9f765",
        "title": "Pfizer",
        "summary": "4,920 trials, 3,337 as lead sponsor, 1,583 as collaborator; 235 recruiting; 2,183 with posted results; 850 drugs on its trials.",
        "record": "/library/companies/pfizer-69d9f765",
        "names": null,
        "trials": 4920,
        "roles": "3,337 as lead sponsor, 1,583 as collaborator",
        "recruiting": 235,
        "with_results": 2183,
        "drugs": 850,
        "phases": "Phase 1 1,419, Phase 2 1,224, Phase 3 893, Phase 4 449"
      }
    ],
    "columns": [
      {
        "key": "title",
        "label": "Company",
        "under": "names"
      },
      {
        "key": "trials",
        "label": "Trials",
        "under": "roles"
      },
      {
        "key": "recruiting",
        "label": "Recruiting"
      },
      {
        "key": "with_results",
        "label": "Posted results"
      },
      {
        "key": "drugs",
        "label": "Drugs"
      },
      {
        "key": "phases",
        "label": "Trials by phase"
      }
    ],
    "order": "Most trials first",
    "kinds": {
      "all": 18985,
      "recruiting": 5232,
      "with-results": 5375
    }
  },
  "release": "companies-2026-11-14-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ChEMBL",
      "license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
      "notice": null,
      "short": null
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
      "short": "No license stated"
    },
    {
      "source": "Open Targets",
      "license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
      "notice": null,
      "short": "CC0 1.0"
    }
  ],
  "next": "/api/companies/v1?page=2",
  "request_id": "N1f_YoiUvlKUapOF"
}